Maguindra, Nashrief A.
HRN: 16-30-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2022
CEFUROXIME 1.5GM (VIAL)
05/28/2022
06/02/2022
IV
640mg
Q8hrs
Urinary Tract Infection
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes